Entopsis
Biotechnology ResearchFlorida, United States2-10 Employees
Entopsis is a biotechnology research company based in Miami, Florida, that leverages a proprietary material science screening platform to develop cost-effective products with potential diagnostic and life sciences applications. Its offerings include OpsisDx, a universal platform intended to diagnose cancer and various diseases through urine, and PCRopsis, a series of technologies designed to reduce time and costs in life sciences workflows. The company positions itself in the biotechnology research sector by providing screening-based solutions that aim to streamline diagnostics and laboratory processes for researchers and healthcare-related users. Founded and operating from the Miami area, Entopsis has pursued a range of applications, including an initiative to apply its platform to plant testing through PlantOpsis, reflecting its interest in expanding beyond human health diagnostics. The organization emphasizes a small team structure and a focus on developing impactful, accessible tools within its niche of material science-driven screening.